Outcome of 12-weeks Triple Therapy (TT), including Sofosbuvir (SOF), Ribavirin and Pegylated interferon-Alfa in all non-cirrhotic patients with chronic Hepatitis-C Genotype-3 infection. (2024). Medical Forum Monthly, 28(7). https://medicalforummonthly.com/index.php/mfm/article/view/4148